March 2012
Volume 53, Issue 14
Free
ARVO Annual Meeting Abstract  |   March 2012
TGF-β1 Induced Rises in Il-6 Release and α-sma Expression Depend On ROS Formation and TRPV1 Activation
Author Affiliations & Notes
  • Yuanquan Yang
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Hua Yang
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Zheng Wang
    Biological Sciences, SUNY College of Optometry, New York, New York
  • J Mario Wolosin
    Ophthalmology, Mount Sinai School of Med, New York, New York
  • Peter S. Reinach
    Biological Sciences, SUNY College of Optometry, New York, New York
  • Footnotes
    Commercial Relationships  Yuanquan Yang, None; Hua Yang, None; Zheng Wang, None; J Mario Wolosin, None; Peter S. Reinach, None
  • Footnotes
    Support  EY04795
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1085. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Yuanquan Yang, Hua Yang, Zheng Wang, J Mario Wolosin, Peter S. Reinach; TGF-β1 Induced Rises in Il-6 Release and α-sma Expression Depend On ROS Formation and TRPV1 Activation. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1085.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Transforming growth factor (TGF)-β1- induced increases in IL-6 release and α-smooth muscle actin (SMA) expression in corneal fibroblasts require activation of the transient receptor potential vanilloid1 (TRPV1) (Okada, Y et al American Journal of Pathology 2011). This study examined if this dependence involves increases in reactive oxygen species (ROS) production and modulation of SMAD2 phosphorylation.

Methods: : Stromal fibroblasts were isolated from fresh human cadaver corneas (New York Upstate Transplant Service) and cultured following a described method. Flow cytometry assessed TGF-β1-induced ROS production. TGF-β1 and H2O2- induced Ca2+ transients were determined by image analysis, α-SMA expression and SMAD2 phosphorylation by immunoblotting and the effect of TGF-β1 on IL-6 release by ELISA.

Results: : TGF-β1 (1 ng/ml) treatment for 1 h increased ROS production by 1.5-fold. A ROS scavenger, N-acetyl-L-cysteine (10 mM), or the NADPH oxidase inhibitor, diphenylene iodonium (10 μM), abolished a TGF-β1- induced persistent SMAD2 phosphorylation (15 min and 16 h) as well as increases in α-SMA expression and IL-6 release. TGF-β1 and H2O2 (0.5 mM) induced Ca2+ transients, which were attenuated by capsazepine (CPZ, 10 µM), a selective TRPV1 antagonist. Similarly, either CPZ or withdrawal of extracellular Ca2+ inhibited TGF-β1-induced p-SMAD2 formation. TRPV1 siRNA gene silencing also suppressed TGF-β1-induced increases in SMAD2 phosphorylation, IL-6 release and α-SMA expression (vs. effects on cells transfected instead with scrambled siRNA).

Conclusions: : TGF-β1 induced increases in α-SMA expression and IL-6 release in human corneal fibroblasts depend on ROS formation and subsequent, TRPV1-dependent, Ca2+ spikes. Increases in ROS formation driven by TGF-β1 transactivate TRPV1, which in turn contributes to SMAD2 phosphorylation.

Keywords: cornea: stroma and keratocytes • wound healing 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×